Exagen XGN
Exagen Inc. · Nasdaq · Services-Medical Laboratories
$8.40+7.97%close on Oct. 28, 2026 · volume 348K · Yahoo Finance
Price, last 47 sessions
Our coverage
Nothing published yet.
Insider buying and selling
| Date | Insider | Trade | Shares | Avg. price | Value |
|---|---|---|---|---|---|
| Oct. 19, 2026 | Jorey Chernett 10% owner | Bought | 14,000 | $7.46 | $104,440 |
| Oct. 16, 2026 | John Aballi President and CEO, director | Sold | 34,294 | $7.87 | $269,791 |
| Sept. 1, 2026 | Jeffrey G. Black Chief Financial Officer | Sold | 20,614 | $7.22 | $148,782 |
Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.
Recent SEC filings
All 8 →Results of operations and financial condition · Financial statements and exhibits